Sol-Gel Technologies Ltd. (SLGL)

Sol-Gel Technologies Ltd. (SLGL)

$10.01 USD

0.09 (-0.89%)

Updated Jul 17 4:00pm

Add SLGL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

SLGL Daily Price Range
SLGL 52-Week Price Range

SLGL News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All SLGL News

Sol-Gel Technologies Ltd. (SLGL) Company Bio

Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company’s lead product candidates include VERED that has completed Phase II clinical trials for the treatment of papulopustular rosacea; and TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris. It is also involved in the development of generic dermatological candidates; and formulation and pre-clinical development of early stage product candidates for acne and rosacea, and other dermatological indications. The company was founded in 1997 and is based in Ness Ziona, Israel

SLGL Stock Chart More Charts

SLGL Price/Volume Stats

Current price $10.01
Prev. close $10.10
Day low $9.93
Day high $10.40
50-day MA $8.82
200-day MA $7.20
52-week high $11.36
52-week low $5.41
Volume 11,711
Avg. volume 16,066
Dividend yield N/A
Market Cap 189.42M

SLGL Social Stream

Loading social stream, please wait...

View Full SLGL Social Stream

SLGL Returns

1-mo 16.67%
3-mo 44.03%
6-mo 72.29%
1-year 43.41%
3-year N/A
5-year N/A
YTD 66.28%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Page generated in 0.4024 seconds.